NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers

被引：0
|
作者：
Chrissie E. B. Ong
Amanda L. Patchett
Jocelyn M. Darby
Jinying Chen
Guei-Sheung Liu
A. Bruce Lyons
Gregory M. Woods
Andrew S. Flies
机构：
[1] Menzies Institute for Medical Research,Department of Ophthalmology
[2] College of Health and Medicine,Ophthalmology, Department of Surgery
[3] University of Tasmania,Tasmanian School of Medicine, College of Health and Medicine
[4] The First Affiliated Hospital of Jinan University,undefined
[5] University of Melbourne,undefined
[6] University of Tasmania,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2021年 / 147卷
关键词：
Transmissible cancer; Devil facial tumor; Allograft; MHC-I; NLRC5; Immune evasion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1973 / 1991
页数：18
相关论文
共 50 条
  • [1] NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers
    Ong, Chrissie E. B.
    Patchett, Amanda L.
    Darby, Jocelyn M.
    Chen, Jinying
    Liu, Guei-Sheung
    Lyons, A. Bruce
    Woods, Gregory M.
    Flies, Andrew S.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (07) : 1973 - 1991
  • [2] NLRC5 regulates MHC-I expression and immunity during viral infection
    Lupfer, Christopher
    Stokes, Kate
    Kanneganti, Thirumala-Devi
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [3] Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I–deficient breast cancer cells
    Ming-Zhen Zhao
    Yu Sun
    Xiao-Feng Jiang
    Li Liu
    Li Liu
    Li-Xin Sun
    Immunologic Research, 2019, 67 : 497 - 504
  • [4] Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I-deficient breast cancer cells
    Zhao, Ming-Zhen
    Sun, Yu
    Jiang, Xiao-Feng
    Liu, Li
    Liu, Li
    Sun, Li-Xin
    IMMUNOLOGIC RESEARCH, 2019, 67 (06) : 497 - 504
  • [5] PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity
    Djajawi, Tirta M.
    Pijpers, Lizzy
    Srivaths, Akash
    Chisanga, David
    Chan, Kok Fei
    Hogg, Simon J.
    Neil, Liam
    Rivera, Sarahi Mendoza
    Bartonicek, Nenad
    Ellis, Sarah L.
    Sian, Terry C. C. Lim Kam
    Faridi, Pouya
    Liao, Yang
    Pal, Bhupinder
    Behren, Andreas
    Shi, Wei
    Vervoort, Stephin J.
    Johnstone, Ricky W.
    Kearney, Conor J.
    CELL REPORTS, 2024, 43 (03):
  • [6] MHC class I transactivator NLRC5 in host immunity, cancer and beyond
    Cho, Steven X.
    Vijayan, Saptha
    Yoo, Ji-Seung
    Watanabe, Toshiyuki
    Ouda, Ryota
    An, Ning
    Kobayashi, Koichi S.
    IMMUNOLOGY, 2021, 162 (03) : 252 - 261
  • [7] NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity
    Santharam, Madanraj Appiya
    Shukla, Akhil
    Levesque, Dominique
    Kufer, Thomas A.
    Boisvert, Francois-Michel
    Ramanathan, Sheela
    Ilangumaran, Subburaj
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [8] NLRC5/MHC class I transactivator is a target for immune evasion in cancer
    Yoshihama, Sayuri
    Roszik, Jason
    Downs, Isaac
    Meissner, Torsten B.
    Vijayan, Saptha
    Chapuy, Bjoern
    Sidiq, Tabasum
    Shipp, Margaret A.
    Lizee, Gregory A.
    Kobayashi, Koichi S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (21) : 5999 - 6004
  • [9] Genetic aberrations of NLRC5 are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma
    Gunawardana, Jay
    Lee, Justina N.
    Bednarska, Karolina
    Murigneux, Valentine
    de Long, Lilia Merida
    Sabdia, Muhammed B.
    Birch, Simone
    Tobin, Joshua W. D.
    Gandhi, Maher K.
    EJHAEM, 2020, 1 (02): : 517 - 526
  • [10] The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation
    Zhu, Baohui
    Ouda, Ryota
    An, Ning
    Tanaka, Tsutomu
    Kobayashi, Koichi S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (05)
12345